HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 224 filers reported holding HORIZON PHARMA PLC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $558,000 | +22.9% | 21,100 | -9.2% | 0.03% | -3.6% |
| Q4 2018 | $454,000 | -25.0% | 23,232 | -24.8% | 0.03% | +21.7% |
| Q3 2018 | $605,000 | +295.4% | 30,907 | +187.6% | 0.02% | +283.3% |
| Q1 2018 | $153,000 | -6.7% | 10,745 | -4.3% | 0.01% | 0.0% |
| Q4 2017 | $164,000 | +0.6% | 11,230 | -12.6% | 0.01% | -14.3% |
| Q3 2017 | $163,000 | +10.9% | 12,855 | +3.9% | 0.01% | 0.0% |
| Q2 2017 | $147,000 | -26.5% | 12,376 | -8.4% | 0.01% | -22.2% |
| Q1 2017 | $200,000 | -7.8% | 13,508 | +0.8% | 0.01% | -10.0% |
| Q4 2016 | $217,000 | -14.2% | 13,396 | -4.0% | 0.01% | -16.7% |
| Q3 2016 | $253,000 | +30.4% | 13,958 | +18.8% | 0.01% | +33.3% |
| Q2 2016 | $194,000 | -17.1% | 11,752 | +8.9% | 0.01% | -18.2% |
| Q4 2015 | $234,000 | +0.4% | 10,790 | -8.2% | 0.01% | -15.4% |
| Q3 2015 | $233,000 | – | 11,748 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
| Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
| Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
| Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
| Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |